Neonatology & Resuscitation
Correct
Clinical Rationale:
According to the Saudi MOH National Immunization Schedule, the 9-month visit specifically includes the single-antigen Measles vaccine and the first dose of Quadrivalent Meningococcal Conjugate (MCV4).
Clinical Synthesis
The Saudi Arabian National Immunization Program (NIP) includes unique schedule modifications tailored to regional epidemiology and Hajj/Umrah pilgrimages:
- At Birth: BCG and Hepatitis B.
- At 2, 4, and 6 Months: Hexavalent (DTaP-IPV-HepB-Hib), PCV13, and Oral Rotavirus.
- At 9 Months: Single Measles and MCV4 (Meningococcal conjugate) dose 1.
- At 12 Months: MMR dose 1, PCV13 booster, Varicella dose 1, MCV4 dose 2.
- At 18 Months: Hexavalent booster, OPV, MMR dose 2, Varicella dose 2, Hepatitis A dose 1.
- At 24 Months: Hepatitis A dose 2.
Saudi MOH Pediatric Vaccination Schedule Matrix
| Age | Vaccines Administered under Saudi MOH Blueprint |
|---|---|
| Birth | BCG, Hep B |
| 2, 4, 6 Mos | Hexavalent (DTaP-IPV-HepB-Hib), PCV13, Rotavirus |
| 9 Months | Measles (Monovalent), MCV4-1 |
| 12 Months | MMR-1, PCV13 (Booster), Varicella-1, MCV4-2 |
| 18 Months | DTaP-IPV-Hib, OPV, MMR-2, Varicella-2, Hep A-1 |
Distractor Differential Breakdown
- Option A (MMR + Varicella): Administered at 12 months and 18 months, not 9 months.
- Option B (Hexavalent + PCV13): Administered at 2, 4, and 6 months, with boosters at 12 and 18 months.
- Option C (BCG + Hep B): Given immediately at birth before hospital discharge.
Exam Trap
Do not confuse the 9-month visit with the 12-month visit. In the Saudi MOH schedule, monovalent Measles and MCV4 dose 1 are given at 9 months. MMR, Varicella, and PCV13 booster are deferred until 12 months.
Clinical Pearl
The 9-month Measles and MCV4 requirement is a frequently tested, distinctive hallmark of the Saudi National Immunization Schedule on the SMLE, differing from standard CDC/WHO schedules.
Practise questions in Pediatrics
Complete full timed computer-based blocks with instant psychometric score conversion.